公开(公告)号：EP2578232A4

公开(公告)日：2013-11-20

申请号：EP11789905

申请日：2011-06-02

申请人： DAINIPPON SUMITOMO PHARMA CO

发明人： KINO KOICHI ,  KAI TOSHIHIRO ,  MATSUMOTO MITSUHIRO ,  KAJIKAWA MASUNORI ,  SUGIURA MASAHITO ,  SHIMIZU EMI

IPC分类号： A61K39/395 ,  A61P1/04 ,  A61P11/06 ,  A61P17/04 ,  A61P17/06 ,  A61P25/00 ,  A61P29/00 ,  A61P37/02 ,  A61P37/08 ,  C07K16/28 ,  C12Q1/02 ,  C12Q1/68 ,  G01N33/53

CPC分类号： C07K16/42 ,  A61K39/39533 ,  A61K2039/505 ,  C07K16/2803 ,  C07K2317/73 ,  C12Q1/6888 ,  G01N33/505 ,  G01N33/6893 ,  G01N2333/4703

摘要： The present invention provides an agent for the prophylaxis or therapy of autoimmune diseases or allergic diseases, which contains an anti-Embigin antibody, particularly an anti-Embigin antibody showing cytotoxicity or a cytotoxicity inducing activity, an agent for the prophylaxis or therapy of diseases involving Th17 cell, and a cytotoxic agent to Th17 cell. In addition, an agent for detection of Th17 cell, which contains an anti-Embigin antibody, a convenient detection method of Th17 cell, which uses the agent, a method of efficiently delivering a drug and the like in a Th17 cell selective manner, which uses an anti-Embigin antibody, and a drug delivery system to Th17 cell are provided.